Cite

HARVARD Citation

    Xin, Y. et al. (2019). Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes. Lancet. 7 (3), pp. 169-172. [Online]. 
  
Back to record